Nutritional and Metabolic Diseases

Gland and Hormone Related Diseases

All Conditions

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Respiratory Tract (Lung and Bronchial) Diseases

Symptoms and General Pathology

Infections

Heart and Blood Diseases

Rare Diseases

Prediabetic State

Kidney Diseases

Lung Diseases, Obstructive

Pulmonary Disease, Chronic Obstructive

COVID-19

Heart Failure

Atrial Fibrillation

Urolithiasis

Coronary Artery Disease

Myocardial Ischemia

Hypertension

Heart Diseases

Glucose Intolerance

Ischemia

Lung Diseases

Urinary Calculi

Albuminuria

Renal Insufficiency, Chronic

Renal Insufficiency

Coronary Disease

Vascular Diseases

Arrhythmias, Cardiac

Urologic Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Male Urogenital Diseases

Respiratory Tract Diseases

Chronic Disease

Disease Attributes

Arteriosclerosis

Arterial Occlusive Diseases

Proteinuria

Urination Disorders

Urological Manifestations

Chronic Graft Versus Host Disease

Patients aged 40 or older without preexisting diagnoses of chronic kidney disease, type 1 diabetes, and type 2 diabetes with positive albuminuria by dipsticks and/or microalbuminuria test or albumin-to-creatinine ratio in a single urine sample.

Elena Semenova, PhD

Alexander Vaskin

Alexander Arutyunov, professor

Real clinical practice register of Albuminuria detection in patients with previously undiagnosed chronic kidney disease

This register was sponsored and organized by the Association "Eurasian Association of Internal Medicine". It is a multicenter non-interventional register of real clinical practice. The database will include patients aged 40 years and older without pre-existing nephrological disease who are available for a dipstick test for albuminuria. The subjects will be identified by screening all patients who meet inclusion/exclusion criteria during routine outpatient and hospital follow-up. The register does not include follow-up (cross-sectional design).

Patients eligible for the register should be enrolled and documented. The procedure for obtaining informed consent for the collection and analysis of the retrospective data must comply with the local legislation. If necessary, patients will be asked to sign an informed consent document.

All study sites will use standardized electronic CRFs. The Electronic Data Capture (EDC) system should be validated in accordance with current standards and legal requirements. The investigators will log into this system using individual usernames and passwords. Data may only be entered and corrected by the investigator or other authorized study site personnel.

Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease

Eurasian Association of Therapists

Neoplasms

Adenocarcinoma

Atherosclerosis

Prostatic Neoplasms

Carcinoma

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases

Genital Diseases, Male

Prostatic Diseases

ISCHEMIC HEART DISEASE diagnostic

The purpose of the study: to increase the efficiency of diagnosis, treatment and prediction of the course of coronary heart disease in patients with adenocarcinoma of the prostate gland, depending on the hormonal status by determining the cardiovascular risk factors, factors of angiogenesis, structural and functional state of the heart, coronary vessels, kidney damage and their pharmacological correction.

Research methods:

1. general-clinical examination
2. Laboratory methods:

   * estimation of the generally accepted laboratory parameters
   * determination of blood lipid profile
   * Determination of the level of highly sensitive CRP by the method of immuno-enzyme analysis,
   * determination of the level of proteinuria, creatinine by the method of immuno-enzyme analysis with the subsequent calculation of GFR
   * determination of the level of insulin by the method of immuno-enzyme analysis with the subsequent calculation of indices of insulin resistance,
   * determination of the level of blood testosterone by the method of immuno-enzyme analysis,
   * determination of the levels of vascular-endothelial growth factor, angiosetamine by the immuno-enzyme assay,
3. Echo-doppler examination of vessels (endothelium-dependent vasodilatation with reactive hyperemia, determination of the thickness of CIM, GPI)
4. Ultrasound examination of the main vessels of the head and neck
5. ECG
6. Daily monitoring of BP
7. CT-angiographic examination of coronary vessels with the definition of the index of calcification
8. Statistical methods

Ischemic Heart Disease in Male With Prostate Adenocarcinoma

Ischemic Heart Disease in Male With Prostate Adenocarcinoma: Clinical and Pathogenetic Aspects of Diagnostics, Prognosis and Treatment

cardiovascular events development - myocardial infarction, stroke

Dnipropetrovsk State Medical Academy

professor assistant

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease	NCT05690009	Chronic Kidney ... Hypertension Chronic Heart F... Ischemic Heart ... Atrial Fibrilla... PreDiabetes Chronic Obstruc... Cancer Urolithiasis COVID-19		40 Years -	Eurasian Association of Therapists
Ischemic Heart Disease in Male With Prostate Adenocarcinoma	NCT03474835	Ischemic Heart ... Prostate Adenoc...	ISCHEMIC HEART ...	-	Dnipropetrovsk State Medical Academy
Ischemic Heart Disease in Male With Prostate Adenocarcinoma	NCT03474835	Ischemic Heart ... Prostate Adenoc...	ISCHEMIC HEART ...	-	Dnipropetrovsk State Medical Academy

Spots Global Cancer Trial Database for ischemic heart disease